1985•PubMedRequires access

[Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].

Dominique Alix, Francois Berthou, Christian Riché, H Gouédard

Open publisher page 0 citations

Abstract

Theophylline has been administered to 76 premature infants with apnea in two therapeutic indications: curative and preventive treatment. Plasmatic theophylline and caffeine concentrations have been performed by gas chromatography for ten days for the determination of the therapeutic range. The maximum effective concentration has been defined from the data observed in 33 subjects presenting with symptoms considered as signs of toxicity. The minimum effective concentration has been determined from the data observed during the failure of treatment (n = 4) and at the reappearance of apnea at the end of treatment (n = 10). The therapeutic concentrations of theophylline has be found on average to be 3 to 8 mg/l and for the theophylline and caffeine together from 5 to 10 mg/l. The sum theophylline and caffeine data is better for therapeutic monitoring than the determination of theophylline alone.

About this research paper

What this paper is about

Theophylline has been administered to 76 premature infants with apnea in two therapeutic indications: curative and preventive treatment. Plasmatic theophylline and caffeine concentrations have been performed by gas chromatography for ten days for the determination of the therapeutic range. The maximum effective concentration has been defined from the data observed in 33 subjects presenting with symptoms considered as signs of toxicity. The minimum effective concentration has been determined from the data observed during the failure of treatment (n = 4) and at the reappearance of apnea at the end of treatment (n = 10). The therapeutic concentrations of theophylline has be found on average to be 3 to 8 mg/l and for the theophylline and caffeine together from 5 to 10 mg/l. The sum theophylline and caffeine data is better for therapeutic monitoring than the determination of theophylline alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Theophylline has been administered to 76 premature infants with apnea in two therapeutic indications: curative and preventive treatment. Plasmatic theophylline and caffeine concentrations have been performed by gas chromatography for ten days for the determination of the therapeutic range. The maximum effective concentration has been defined from the data observed in 33 subjects presenting with symptoms considered as signs of toxicity. The minimum effective concentration has been determined from the data observed during the failure of treatment (n = 4) and at the reappearance of apnea at the end of treatment (n = 10). The therapeutic concentrations of theophylline has be found on average to be 3 to 8 mg/l and for the theophylline and caffeine together from 5 to 10 mg/l. The sum theophylline and caffeine data is better for therapeutic monitoring than the determination of theophylline alone.

Key concepts: Theophylline, Caffeine, Therapeutic index, Apnea, Therapeutic effect, Medicine, Anesthesia, Apnea of prematurity

Related papers

Back to paper searchBrowse research topicsOriginal source
[Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline]. — Research Paper | ScholarLens